Phathom Pharmaceuticals, Inc. - Common Stock, $0.0001 par value per share (PHAT)

169 filings reported holding PHAT - Phathom Pharmaceuticals, Inc. - Common Stock, $0.0001 par value per share as of Q4 2024.
Phathom Pharmaceuticals, Inc. - Common Stock, $0.0001 par value per share (PHAT) has 140 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 66.6M shares of 69.6M outstanding shares and own 95.7% of the company stock.
Largest 10 shareholders include Frazier Life Sciences Management, L.P. (10.1M shares), Medicxi Ventures Management (Jersey) Ltd (7.46M shares), JENNISON ASSOCIATES LLC (7.06M shares), Invesco Ltd. (3.67M shares), BlackRock, Inc. (3.5M shares), Carlyle Group Inc. (3.5M shares), VANGUARD GROUP INC (2.78M shares), Ensign Peak Advisors, Inc (2.53M shares), Checkpoint Capital L.P. (2.27M shares), and NEA Management Company, LLC (1.96M shares).
This table shows the top 140 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.